[
    [
        {
            "time": "",
            "original_text": "沃森生物回应投资者‘贱卖’质疑：保持交流争取理解",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖",
                    "投资者",
                    "质疑",
                    "交流",
                    "理解"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物回应投资者‘贱卖’质疑：保持交流争取理解",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "21深度｜沃森生物转让HPV疫苗公司风波：及时止损还是放弃押注？",
            "features": {
                "keywords": [
                    "沃森生物",
                    "HPV疫苗",
                    "转让",
                    "止损",
                    "争议"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "21深度｜沃森生物转让HPV疫苗公司风波：及时止损还是放弃押注？",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫苗股沃森生物被指贱卖资产 管理层遭投资者怒怼：你们不相信因果报应吗？ 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖",
                    "资产",
                    "管理层",
                    "投资者",
                    "因果报应"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗股沃森生物被指贱卖资产 管理层遭投资者怒怼：你们不相信因果报应吗？ 资产异常",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "视频：700亿疫苗巨头要‘贱卖’资产？投资者炸锅！",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖",
                    "资产",
                    "投资者",
                    "情绪"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "视频：700亿疫苗巨头要‘贱卖’资产？投资者炸锅！",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "700亿疫苗股要贱卖资产？机构电话会议怒怼",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖",
                    "资产",
                    "机构",
                    "电话会议"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "700亿疫苗股要贱卖资产？机构电话会议怒怼",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "放弃HPV疫苗子公司控股权引争议 沃森生物董事长李云春：蛋糕做大了仍能分享收益",
            "features": {
                "keywords": [
                    "沃森生物",
                    "HPV疫苗",
                    "控股权",
                    "争议",
                    "李云春",
                    "收益"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "放弃HPV疫苗子公司控股权引争议 沃森生物董事长李云春：蛋糕做大了仍能分享收益",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]